OTCMKTS:RYMDF Relay Medical (RYMDF) Stock Price, News & Analysis $0.08 0.00 (0.00%) As of 06/8/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Relay Medical Stock (OTCMKTS:RYMDF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Relay Medical alerts:Sign Up Key Stats Today's Range$0.08▼$0.0850-Day Range$0.07▼$0.0852-Week Range$0.13▼$0.72VolumeN/AAverage Volume68,743 shsMarket Capitalization$18.86 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Relay Medical Corp. operates as a medical technology company, which engages in the development of novel medical devices for in vitro diagnostics and point-of-care testing. Its platform technologies include HemoPalm and Pharmatrac. The HemoPalm develops a POCT unit-use cartridge based blood analyzer with full enterprise capabilities. The Pharmatrac is an AI and data analytics driven personal medication management system that addresses the growing problem of non-adherence to treatment. The company was founded by James Samsoondar in 2005 and is headquartered in Toronto, Canada. Read More Receive RYMDF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Relay Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RYMDF Stock News HeadlinesCNN’s Top Doc Relays Medical Community’s ‘Horror’ Over RFK Jr.November 15, 2024 | msn.comRelay Therapeutics' combo therapy for breast cancer cuts disease progression in early studySeptember 9, 2024 | reuters.comThe tiny chipmaker set to supply Musk 5 billion chipsSpaceX and xAI just completed a $1.25 trillion merger - and Musk may no longer need data centers from Microsoft, Amazon, or Google. Tech expert and angel investor Jeff Brown has identified one chipmaker, 148 times smaller than NVIDIA, that is set to supply Musk with 5 billion chips over the next two years. Brown brings decades of senior executive experience at Qualcomm, Juniper Networks, and NXP Semiconductors to this call.June 10 at 1:00 AM | Brownstone Research (Ad)Relay Therapeutics Shares Jump on Positive Results for Breast Cancer TreatmentSeptember 9, 2024 | marketwatch.comRelay stock rallies 41% on positive data for RLY-2608September 9, 2024 | msn.comJoin Relay and 9to5Mac in supporting St. Jude Children’s Research HospitalAugust 28, 2024 | 9to5mac.com9'Relay FM' Podcast Network Launches Annual Fundraiser for St. Jude Children's Research HospitalAugust 28, 2024 | macrumors.comMAmericans run blazing time in 4×100-meter relay — and could still get benched for Olympic finalsAugust 10, 2024 | nypost.comNSee More Headlines RYMDF Stock Analysis - Frequently Asked Questions How have RYMDF shares performed this year? Relay Medical's stock was trading at $0.0725 at the start of the year. Since then, RYMDF stock has increased by 7.9% and is now trading at $0.0782. How do I buy shares of Relay Medical? Shares of RYMDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today6/10/2026Fiscal Year End9/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:RYMDF CIKN/A Webwww.relaymedical.com Phone(647) 872-9982FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares241,197,000Free FloatN/AMarket Cap$18.86 million OptionableNot Optionable Beta1.15 Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (OTCMKTS:RYMDF) was last updated on 6/10/2026 by MarketBeat.com Staff. From Our PartnersOne hidden supplier shipped 5 billion parts to SpaceXMost investors are focused on the historic $1.75 trillion SpaceX IPO expected around June 30. But there's a le...Weiss Ratings | SponsoredI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...Brownstone Research | SponsoredHe Called NVIDIA at $1.10 – Now He Says, “SELL”The analyst who called NVIDIA at $1.10 now says sell. According to Alexander Green, Chief Investment Strategis...The Oxford Club | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredThis IPO Could Make SpaceX Look Small (Read before June 16)A red-hot AI startup just filed to go public - already valued at nearly $1 trillion. Wall Street veteran Marc ...Chaikin Analytics | SponsoredThe part that convinced me Joel is legitMost trading gurus cite big win rates but won't let you verify them. Joel Peterson is different - his trade pl...Crypto Swap Profits | SponsoredImportant SpaceX PREDICTIONThe biggest IPO in stock market history could go live as soon as June 12th — but trading legend Jon Najarian s...Banyan Hill Publishing | SponsoredIn 30 days, you'll wish you'd read this emailA small power equipment company with $1.5 billion in orders is flying under the radar - but not for long. When...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relay Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Relay Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
